Cargando…
Research progress of metabonomics of blood endogenous small molecules in depression
INTRODUCTION: Depression (MDD) is a serious mental illness, which greatly affects the quality of life of patients. Nowadays, the clinical diagnosis of MDD lacks sufficient objective basis, and the effect of drug treatment is unsatisfactory. Therefore, biomarkers are very important for the risk predi...
Autores principales: | Zhang, Y., Ding, J., Cui, X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480031/ http://dx.doi.org/10.1192/j.eurpsy.2021.2055 |
Ejemplares similares
-
Metabonomics Research Progress on Liver Diseases
por: Yu, Mengqian, et al.
Publicado: (2017) -
Progress in Metabonomics of Type 2 Diabetes Mellitus
por: Ma, Quantao, et al.
Publicado: (2018) -
Types of apathetic depressions formed in endogenous diseases.
por: Barkhatova, A., et al.
Publicado: (2023) -
Stages of treatment of eating disorders in endogenous depressions
por: Barkhatova, A., et al.
Publicado: (2023) -
Psychopathological and clinical-typological aspects of youth chronic endogenous depression
por: Kaleda, V., et al.
Publicado: (2022)